Mechanistically, T cell-derived IFNγ increased the susceptibility of tumor cells to T cell recognition and elimination via upregulation of MHC molecules and IFNγ-mediated tumoricidal activity (Fig. 5e)61. The gene discussed is IFNG; the disease is neoplasm.